- Telehealth Visits
- Insurance plan information
John P. Kane, MD, PhD
EndocrinologyDirector, Adult Lipid Clinic- Telehealth Visits
- Insurance plan information
John P. Kane, MD, PhD
EndocrinologyDirector, Adult Lipid Clinic- Telehealth Visits
- Insurance plan information
On this page
About me
Dr. John Kane is an endocrinologist and director of the UCSF Lipid Clinic. He is also an associate director of the UCSF Cardiovascular Research Institute.
Kane's research on lipoprotein metabolism, the management of lipoprotein disorders, and the genetic basis of heart disease and stroke is known worldwide through his publications in refereed journals and book chapters.
Kane earned his medical degree at the University of Oregon School of Medicine. He completed a residency in internal medicine at Stanford University and UCSF, followed by a fellowship in endocrinology at UCSF.
Kane was an Established Investigator and fellow of the American Heart Association. He received an outstanding achievement award from the International Atherosclerosis Society for his work in the genetics of lipoprotein metabolism and atherosclerosis. He is a diplomate of the American Board of Clinical Lipidology.
Education & training
Fellowship
- Endocrinology, UCSF Medical Center GME/RESEARCH
Residency
- Internal Medicine, Stanford University Internal Medicine Residency
Internship
- Rotating, Santa Clara Valley Medical Center GME
Degree
- MD, Oregon Health & Science University
My expertise
Specialties
Clinical Trials query: q=health_gateway_id_ss%3A%28%22311%22%29+AND+status_s%3A%28%22Recruiting%22%29&rows=4&sort=date_published+desc&fq=content_type%3A%22Clinical+Trial%22
Puiblications query: q=health_gateway_id_ss%3A%28%22311%22%29&rows=4&sort=date_published+desc&fq=content_type%3A%22Publication%22
For informational purposes only, a link to the federal Centers for Medicare and Medicaid Services (CMS) Open Payments web page is provided here. The federal Physician Payments Sunshine Act requires that detailed information about payment and other payments of value worth over ten dollars ($10) from manufacturers of drugs, medical devices, and biologics to physicians and teaching hospitals be made available to the public.